6505-01-292-5620 ( TAGEMET INJECT , NDC00108-5017-13 )
NSN Information
| NSN | FSC | NIIN | Item Name | INC |
|---|---|---|---|---|
| 6505-01-292-5620 | 6505 | 012925620 | CIMETIDINE HYDROCHLORIDE INJECTI | 6655 |
NSN Features
| MRC | Parameter | Characteristics |
|---|---|---|
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 2.000 MILLILITERS |
| CQCT | PRIMARY CONTAINER TYPE | VIAL |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 30 |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 300.000 MILLIGRAMS CIMETIDINE HYDROCHLORIDE ACTIVE INGREDIENT |
Manufacturing Part Numbers (SKUs)
| Part SKU | Cage | Status | RNVC | RNCC | SADC | DAC | RNAAC |
|---|---|---|---|---|---|---|---|
| TAGEMET INJECT | 93544 | A | 1 | 5 | 6 | 54 | |
| NDC00108-5017-13 | 93544 | A | 2 | 3 | 6 | 54 |
Manufacturers
| Part SKU | Cage | Manufacturer | Type | Status |
|---|---|---|---|---|
| TAGEMET INJECT | 93544 | GLAXOSMITHKLINE HOLDINGS AMERICA | A | A |
| NDC00108-5017-13 | 93544 | GLAXOSMITHKLINE HOLDINGS AMERICA | A | A |
FLIS Identification
| PMIC | ADPE Code | CRITL Code | DEMIL Code | DEMIL INTG | NIIN Asgt | ESD | HMIC | ENAC | Schedule-B | INC |
|---|---|---|---|---|---|---|---|---|---|---|
| U | X | A | 1 | 01/19/1 | P | 3004909155 | 6655 |
FLIS Management
| MOE | REC Rep Code | Mgmt Ctl | USC | Phrase Code | Phrase Statement |
|---|---|---|---|---|---|
| VA | V | K | U/I CONTAINS 2 ML |
Demilitarization Codes & Management
| DML | PMI | HMIC | ADP | CC | ESDC |
|---|---|---|---|---|---|
| A | U | P | X |
Miscellaneous Management
| MOE (S_A) | SOS | AAC | QUP | UI | SLC | CIIC | RC | MCC | SVC |
|---|---|---|---|---|---|---|---|---|---|
| VA | I | 0 | VI | R | U | V |
Management Control Army
| MATCAT 1 | MATCAT 2 | MATCAT 3 | MATCAT 4 5 | ARC |
|---|
Freight
| NMFC | NMFC SUB | UFC | HMC | LTL | LCL | WCC | TCC | SHC | ADC | ACC | ASH | NMF DESC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|